tradmap

Industries › Healthcare › Medicinal Chemicals & Botanical Products

Medicinal Chemicals & Botanical Products

The 18 US-listed Medicinal Chemicals & Botanical Products companies we cover, ranked by market cap. Updated

Companies
18
Combined market cap
$13.0B
Combined revenue (TTM)
$4.3B
Today
-2.80%
1Y
-37.27%
YTD
+14.55%
Avg yield
9.72%
Largest
DFTX · 33.4%
Best today
TRLV +8.19%
Worst today
DFTX -10.70%

The largest Medicinal Chemicals & Botanical Products companies by market cap: Definium Therapeutics, Inc., Regencell Bioscience Holdings Ltd, Trulieve Cannabis Corp., Cronos Group, Tilray Brands. Together, the 18 companies we cover report $4.3B in combined trailing-twelve-month revenue — the sum of covered companies' reported revenue, not an industry market-size estimate.

Medicinal Chemicals & Botanical Products heatmap

Tile size is market cap; color is the latest daily change.

Technical signals in Medicinal Chemicals & Botanical Products

Chart conditions currently in force among Medicinal Chemicals & Botanical Products stocks — each opens the screener filtered to Medicinal Chemicals & Botanical Products + that signal.

MACD Bullish Medicinal Chemicals & Botanical Products Stocks

Medicinal Chemicals & Botanical Products stocks with a bullish MACD (the MACD line above its signal line). A live technical scan, refreshed daily — informational, not advice.

MACD-bullish screener →

Above the 200-Day Average Medicinal Chemicals & Botanical Products Stocks

Medicinal Chemicals & Botanical Products stocks trading above their 200-day moving average. A live technical scan, refreshed daily — informational, not advice.

Above-200-day screener →

MACD Bearish Medicinal Chemicals & Botanical Products Stocks

Medicinal Chemicals & Botanical Products stocks with a bearish MACD (the MACD line below its signal line). A live technical scan, refreshed daily — informational, not advice.

MACD-bearish screener →

Companies

1–18 of 18
DFTXDefinium Therapeutics, Inc.32.46-10.70%$4.4B
RGCRegencell Bioscience Holdings Ltd6.27-5.00%$3.1B
TRLVTrulieve Cannabis Corp.11.10+8.19%$2.1B
CRONCronos Group3.35+1.52%$1.2B
TLRYTilray Brands2.54+0.40%$375M
SNDLSNDL Inc.1.28+2.81%$337M
CGCCanopy Growth0.68+4.07%$288M
USNAUSANA HEALTH SCIENCES INC14.69+2.69%$271M
ACBAurora Cannabis4.22+3.94%$237M
GLASGlass House Brands Inc.2.34+6.85%$192M
NAGENiagen Bioscience, Inc.2.40+2.56%$190M
MDWDMediWound Ltd.13.51+1.35%$173M
FTLFFITLIFE BRANDS, INC.8.26+4.69%$78M
BTMDbiote Corp.1.14+1.79%$33M
MTEXMANNATECH INC8.23-2.31%$16M
NAIINATURAL ALTERNATIVES INTERNATIONAL INC1.11+1.83%$6M
IMCCIM Cannabis Corp.0.77-2.65%$5M
BONBon Natural Life Ltd1.11-2.19%$3M

Frequently asked questions

How many Medicinal Chemicals & Botanical Products companies are there?

We cover 18 US-listed Medicinal Chemicals & Botanical Products companies as of 2026-11-03, refreshed every trading day.

Who are the largest Medicinal Chemicals & Botanical Products companies?

By market cap, the largest Medicinal Chemicals & Botanical Products companies we cover are Definium Therapeutics, Inc. (DFTX), Regencell Bioscience Holdings Ltd (RGC), Trulieve Cannabis Corp. (TRLV).

What is the combined market cap of the Medicinal Chemicals & Botanical Products industry?

The 18 US-listed Medicinal Chemicals & Botanical Products companies we cover have a combined market capitalization of $13.0 billion as of 2026-11-03.

What is the total revenue of the Medicinal Chemicals & Botanical Products industry?

The combined trailing-twelve-month revenue of the US-listed Medicinal Chemicals & Botanical Products companies we cover is $4.3 billion. This is the sum of covered companies' reported revenue — not an industry market-size estimate.

What is the average dividend yield of Medicinal Chemicals & Botanical Products companies?

The cap-weighted average dividend yield of the Medicinal Chemicals & Botanical Products stocks we cover is 9.72%.

Industry classification from SEC EDGAR (SIC) · Databento EQUS.MINI (prices) · combined figures are sums/averages of the US-listed companies we cover. Informational only — not financial advice.